Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome

Haematologica. 2000 Nov;85(11):1224-5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Diagnosis, Differential
  • Female
  • Glomerulonephritis, Membranous / diagnosis
  • Glomerulonephritis, Membranous / drug therapy
  • Glomerulonephritis, Membranous / etiology
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications*
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Middle Aged
  • Nephrotic Syndrome / diagnosis*
  • Nephrotic Syndrome / drug therapy
  • Nephrotic Syndrome / etiology
  • Proteinuria / drug therapy
  • Proteinuria / etiology
  • Remission Induction
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use*

Substances

  • Antineoplastic Agents
  • Vidarabine
  • fludarabine